myocardial infarction

(redirected from myoblastoma)
Also found in: Dictionary, Thesaurus, Medical.
Related to myoblastoma: medulloblastoma, glioblastoma

myocardial infarction:

see under infarctioninfarction,
blockage of blood circulation to a localized area or organ of the body resulting in tissue death. Infarctions commonly occur in the spleen, kidney, lungs, brain, and heart.
..... Click the link for more information.

Myocardial Infarction


a form of necrosis of the heart muscle caused by an acute insufficiency of blood flow through the coronary arteries nourishing the heart tissues. The coronary insufficiency may be caused either by a sudden interruption of the blood flow through a coronary artery or by a disparity between the oxygen demand of the myocardium and the capacity of the coronary arteries to satisfy it. The anatomical basis of myocardial infarction is in 98 percent of the cases atherosclerosis of the coronary arteries. A sudden acute interruption of coronary circulation resulting in myocardial infarction may follow (1) the narrowing (stenosis) of a coronary artery from pronounced atherosclerosis or the formation of a large atherosclerotic plaque, (2) the occlusion of the lumen of the blood vessel by a thrombus, or (3) a sudden increase in the load on the myocardium and the consequently greater need for oxygen. Young persons may suffer myocardial infarction because of neurohumoral disturbances during spasm of the myocardial blood vessels against a background of only moderate atherosclerosis.

Myocardial infarction generally arises after thrombosis of the coronary vessels. A thrombus in a coronary vessel may result from either systemic disorders (decreased amount of anticoagulants, such as heparin and fibrinolysin, in the blood, reduced capability of a compensatory increase in these substances, increased amount of clotting factors) or local changes (development of rough spots on the intima of a blood vessel, disintegration or ulceration of an atherosclerotic plaque, eddies in the blood flow, slowing of the blood flow). Myocardial infarction often follows an increase in the patient’s ordinary activity. The heart needs more oxygen and nutrients because of the increased load. However, coronary arteries altered by atherosclerosis cannot respond with an adequate increase in the blood flow; this results in myocardial ischemia and sometimes in infarction.

Myocardial infarction was first described in 1909 by the Russian scientists V.P. Obraztsov and N.D. Strazhesko. It affects almost exclusively the walls of the left ventricle, posterior or (most often) anterior. Extensive infarctions extend to most of the anterior or posterior wall and, in 10 to 20 percent of the cases, to the interventricular septum. The necrotic tissues are gradually resorbed and a connective-tissue scar develops on the site in six or seven weeks. The wall at the site of an infarction may become thin; if the infarction is extensive, a cardiac aneurysm may form. Myocardial infarction generally occurs in males over 40 years of age. Smoking, diabetes mellitus, overweight, and a sedentary way of life are predisposing factors.

An infarction is manifested most often by a severe attack of angina pectoris—retrosternal pains radiating to the left arm, back, and shoulder blade. These pains usually cannot be relieved by the ordinary vasodilators (Validol, nitroglycerin) or sometimes even by narcotics. In some cases the initial symptom is a choking sensation without other pain. A gastralgic condition, manifested by pain in the upper part of the stomach, has also been noted. An elevated temperature, an increased leukocyte count, and an accelerated ESR (erythrocyte sedimentation rate) after a few days are characteristic. There is a rise in the levels of certain enzymes in the blood (transaminase, aldolases, the first isoenzyme of lactate dehydrogenase). The precise diagnosis is based on the electrocardiogram.

The severity of the course of myocardial infarction is largely determined by the presence of complications, the most serious being cardiogenic shock. In cardiogenic shock blood pressure falls sharply (below 90/60 mm Hg), cold sweats appear, and there is pronounced general weakness. In almost 90 percent of the cases myocardial infarction is complicated by an abnormal heart beat (arrhythmia). The exclusion of the necrotic part of the myocardium from contractile activity may lead to cardiac insufficiency. In some cases this decrease in the contractile capacity of the heart is compensated by the surviving portions of the myocardium; in other cases signs of cardiac insufficiency appear (dyspnea, suffocation, pulmonary congestion, edema, tachycardia). A rare complication is thromboembolism, which is caused by the transport of part of a thrombus from the heart cavity to various vascular regions.

Treatment of myocardial infarction involves early hospitalization, specialized emergency care, and strict bed rest; the administration of anticoagulants and fibrinolytic agents; pain relievers, such as nitrous oxide and neuroleptic agents; electric impulse therapy to control disturbances of rhythm; and cardiac glycosides and diuretics for cardiac insufficiency.

After recovering from a myocardial infarction, the patient must follow a sparing regimen for five to seven months, relaxing this care only gradually. Work involving great physical exertion or emotional stress is thereafter forbidden. Walking, light physical work (in a kitchen garden or flower garden, housework) and exercise therapy are recommended. Four meals a day (not too heavy) that are rich in vitamins and limited in (but not exclusive of) animal fats, meat broths, concentrated coffee, and tea are recommended.


Chazov, E.I. Trombozy i embolii v klinike vnutrennikh boleznei. Moscow, 1966.
Miasnikov, A.L. Gipertonicheskaia bolezn’ i ateroskleroz. Moscow, 1965.
Shestakov, S.V. Grudnaia zhaba i infarkt miokarda. Moscow, 1962. (Bibliography.)
Voprosy morfologii i patogeneza infarkta. Editor in chief, A.I. Strukov.Moscow, 1959.


References in periodicals archive ?
Ravich, "Malignant granular cell myoblastoma involving the urinary bladder," Annals of Surgery, vol.
Granular cell myoblastoma: an electron microscopic and cytochemical study illustrating the genesis of granules and aging of myoblastoma cells.
Polyhydramnios caused by giant alveolar granular cell myoblastoma. Acta Obstet Gynecol Scand 1986;65(5):519-21.
Granular Cell myoblastoma of the vulva in a 6-year-old girl.
(1) The first report of granular cell tumor is attributed to Abrikossoff in 1926 localized in the tongue and he proposed origin from striated muscle cells and he termed this lesion as myoblastoma. (2) Later the cell of origin became controversial until the most widely accepted theory, that of a Schwann cell origin, apparently because of the positivity of the tumor for the S-100 protein, has been putforth.
Granular cell tumor (GCT), described in 1926 by Abrikossoff, (1) was originally thought to be a muscle tumor and named granular cell myoblastoma. Subsequently, immunohistochemical and electron microscopic studies have shown the tumor to be an S100 protein-positive, Schwann cell-related neoplasm.
Surgical Tumor types Thorotrast DU Ta control Benign tumors Benign fibrous histiocytoma 0 1 0 0 Fibroma 0 1 (a) 0 0 Granular cell myoblastoma 1 0 0 0 Malignant tumors Malignant fibrous histiocytoma 13 7 (a) 2 0 Fibrosarcoma 10 2 0 0 Osteosarcoma 1 2 0 0 (a) One rat had two tumors associated with separate implants.
Initially these tumors were thought to arise from skeletal muscle because of their cytological resemblance to myocytes and were called as granular cell myoblastoma. (1) Granular cell tumors are strongly positive for the panmacrophage antigen CD68 as their granules are lysosomal in nature.
(1) Granular cell tumor was first described by Abrikossoff (2) in 1926 as granular cell myoblastoma, assuming a myogenic origin.
[4] This tumor is also known by other names (e.g., granular cell myoblastoma), but the uncertainty of its origin has perpetuated the term granular cell tumor.
Abrikossoff was the first to describe this tumor in the literature in 1926 as a myoblastoma, since it was reported as a tumor arising from muscle in the tongue.
A report of a granular cell pituicytoma associated with multiple endocrine neoplasia type 2 is in the literature[10]; however, this tumor is an example of a granular cell tumor or granular cell myoblastoma. Interestingly, our patient is the first documented case of pituicytoma that had other documented endocrine neoplasms, namely, multiple parathyroid adenomas and a follicular carcinoma of the thyroid.